Compliance Communications Blog

 

"A Primer in What Not to Do"


10/15/14:
The US Department of recently filed suit against a pharmaceutical company and its founder, owner and Chairman of the Board for violations to the Federal Food, Drug and Cosmetic Act (FD&CA) by manufacturing and distributing “adulterated and misbranded medical devices.”  By itself, DOJ’s decision isn’t groundbreaking news but...

VIEW THE FULL POST